CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
Pacing leads to be implanted according randomization. +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00161538
NCT00161538Phase 4Completed
CompareCT.gov

A Randomized, Prospective Multicenter Study to Examine the Optimal Position of the Atrial Leads for Therapy of the Sinus Node Syndrome

Medtronic BRC·interventional·Posted Sep 12, 2005·Updated Oct 20, 2006

In Brief

A Phase 4 clinical trial evaluating Pacing leads to be implanted according randomization. and Selection 9000 prevent AF an Diagnose AF for Sick Sinus Syndrome. Completed, across 12 sites.

Detailed Summary

The purpose of this study is to determine which of 4 lead positions is most effective for pacemaker patients with Sick Sinus Syndrome in order to avoid development of atrial fibrillation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSick Sinus Syndrome
CountriesGermany
CollaboratorsVitatron GmbH

Timeline

Phase 4CompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 12, 2005
Enrollment StartJul 1, 2000
Study CompletionJun 1, 2006
TodayJul 2, 2026
Posted 20.8 years ago

Interventions

Pacing leads to be implanted according randomization.device

Selection 9000 prevent AF an Diagnose AFdevice